HRP20090054T3 - Piperazine derivatives of alkyl oxindoles - Google Patents
Piperazine derivatives of alkyl oxindolesInfo
- Publication number
- HRP20090054T3 HRP20090054T3 HR20090054T HRP20090054T HRP20090054T3 HR P20090054 T3 HRP20090054 T3 HR P20090054T3 HR 20090054 T HR20090054 T HR 20090054T HR P20090054 T HRP20090054 T HR P20090054T HR P20090054 T3 HRP20090054 T3 HR P20090054T3
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- piperazine derivatives
- halogen
- oxindoles
- alkyl oxindoles
- Prior art date
Links
- 150000005623 oxindoles Chemical class 0.000 title 1
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0400954A HU0400954D0 (en) | 2004-05-11 | 2004-05-11 | Piperazine derivatives of alkyl oxindoles |
HU0500461A HUP0500461A3 (en) | 2005-05-05 | 2005-05-05 | Pyperazine derivatives of alkyl-oxindoles |
PCT/HU2005/000048 WO2005108363A1 (en) | 2004-05-11 | 2005-05-10 | Piperazine derivatives of alkyl oxindoles |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20090054T3 true HRP20090054T3 (en) | 2009-03-31 |
Family
ID=89985994
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20060401A HRP20060401A2 (en) | 2004-05-11 | 2006-11-20 | Piperazine derivatives of alkyl oxindoles |
HR20090054T HRP20090054T3 (en) | 2004-05-11 | 2009-01-29 | Piperazine derivatives of alkyl oxindoles |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20060401A HRP20060401A2 (en) | 2004-05-11 | 2006-11-20 | Piperazine derivatives of alkyl oxindoles |
Country Status (24)
Country | Link |
---|---|
US (1) | US20070219209A1 (xx) |
EP (1) | EP1751106B1 (xx) |
JP (1) | JP2007537226A (xx) |
KR (1) | KR20070011551A (xx) |
AT (1) | ATE412634T1 (xx) |
AU (1) | AU2005240842B2 (xx) |
BG (1) | BG109768A (xx) |
CA (1) | CA2564009A1 (xx) |
CZ (1) | CZ2006778A3 (xx) |
DE (1) | DE602005010694D1 (xx) |
DK (1) | DK1751106T3 (xx) |
EA (1) | EA011280B1 (xx) |
ES (1) | ES2317241T3 (xx) |
HR (2) | HRP20060401A2 (xx) |
IL (1) | IL178759A0 (xx) |
MX (1) | MXPA06013064A (xx) |
NO (1) | NO20065697L (xx) |
NZ (1) | NZ551542A (xx) |
PL (1) | PL1751106T3 (xx) |
PT (1) | PT1751106E (xx) |
RS (1) | RS20060620A (xx) |
SI (1) | SI1751106T1 (xx) |
SK (1) | SK51112006A3 (xx) |
WO (1) | WO2005108363A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007537229A (ja) * | 2004-05-11 | 2007-12-20 | エギシュ ヂョヂセルヂャール エンニュ・エル・テー | ジアルキルオキシインドールの新規なピペラジン誘導体 |
US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4452808A (en) * | 1982-12-07 | 1984-06-05 | Smithkline Beckman Corporation | 4-Aminoalkyl-2(3H)-indolones |
MX173362B (es) * | 1987-03-02 | 1994-02-23 | Pfizer | Compuestos de piperazinil heterociclicos y procedimiento para su preparacion |
FR2635104B1 (fr) * | 1988-08-03 | 1992-04-30 | Synthelabo | Derives d'indolone, leur preparation et leur application en therapeutique |
GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
WO1998008816A1 (fr) * | 1996-08-26 | 1998-03-05 | Meiji Seika Kaisha, Ltd. | Derives d'indoxyle et psychotropes |
-
2005
- 2005-05-10 AT AT05745442T patent/ATE412634T1/de active
- 2005-05-10 WO PCT/HU2005/000048 patent/WO2005108363A1/en active Application Filing
- 2005-05-10 EP EP05745442A patent/EP1751106B1/en active Active
- 2005-05-10 KR KR1020067025135A patent/KR20070011551A/ko not_active Application Discontinuation
- 2005-05-10 SK SK5111-2006A patent/SK51112006A3/sk not_active Application Discontinuation
- 2005-05-10 DE DE602005010694T patent/DE602005010694D1/de active Active
- 2005-05-10 JP JP2007512356A patent/JP2007537226A/ja active Pending
- 2005-05-10 CA CA002564009A patent/CA2564009A1/en not_active Abandoned
- 2005-05-10 NZ NZ551542A patent/NZ551542A/en unknown
- 2005-05-10 MX MXPA06013064A patent/MXPA06013064A/es active IP Right Grant
- 2005-05-10 PL PL05745442T patent/PL1751106T3/pl unknown
- 2005-05-10 SI SI200530563T patent/SI1751106T1/sl unknown
- 2005-05-10 PT PT05745442T patent/PT1751106E/pt unknown
- 2005-05-10 CZ CZ20060778A patent/CZ2006778A3/cs unknown
- 2005-05-10 RS RSP-2006/0620A patent/RS20060620A/sr unknown
- 2005-05-10 ES ES05745442T patent/ES2317241T3/es active Active
- 2005-05-10 US US11/596,466 patent/US20070219209A1/en not_active Abandoned
- 2005-05-10 EA EA200602080A patent/EA011280B1/ru not_active IP Right Cessation
- 2005-05-10 AU AU2005240842A patent/AU2005240842B2/en not_active Ceased
- 2005-05-10 DK DK05745442T patent/DK1751106T3/da active
-
2006
- 2006-10-19 IL IL178759A patent/IL178759A0/en unknown
- 2006-11-20 HR HR20060401A patent/HRP20060401A2/xx not_active Application Discontinuation
- 2006-12-11 BG BG109768A patent/BG109768A/bg unknown
- 2006-12-11 NO NO20065697A patent/NO20065697L/no not_active Application Discontinuation
-
2009
- 2009-01-29 HR HR20090054T patent/HRP20090054T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES2317241T3 (es) | 2009-04-16 |
PT1751106E (pt) | 2009-02-10 |
MXPA06013064A (es) | 2007-04-27 |
ATE412634T1 (de) | 2008-11-15 |
US20070219209A1 (en) | 2007-09-20 |
EA011280B1 (ru) | 2009-02-27 |
DE602005010694D1 (de) | 2008-12-11 |
KR20070011551A (ko) | 2007-01-24 |
SI1751106T1 (sl) | 2009-06-30 |
PL1751106T3 (pl) | 2009-07-31 |
EP1751106A1 (en) | 2007-02-14 |
EA200602080A1 (ru) | 2007-04-27 |
DK1751106T3 (da) | 2009-03-09 |
SK51112006A3 (sk) | 2007-05-03 |
AU2005240842A1 (en) | 2005-11-17 |
BG109768A (bg) | 2008-03-31 |
JP2007537226A (ja) | 2007-12-20 |
NZ551542A (en) | 2010-06-25 |
IL178759A0 (en) | 2007-02-11 |
EP1751106B1 (en) | 2008-10-29 |
CZ2006778A3 (cs) | 2007-03-07 |
CA2564009A1 (en) | 2005-11-17 |
RS20060620A (xx) | 2008-09-29 |
AU2005240842B2 (en) | 2011-10-06 |
HRP20060401A2 (en) | 2007-03-31 |
WO2005108363A1 (en) | 2005-11-17 |
NO20065697L (no) | 2007-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS51994B (en) | DERIVATI PIRIDAZINA | |
DK1856045T3 (da) | 1-eddikesyreindolderviater med PGD2-antagonisteffekt | |
RS50437B (sr) | Benzoilpirazoli i njihova primena u ulozi herbicida | |
RS54260B1 (en) | AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT | |
RS50519B (sr) | Supstituisani derivati 8'-piri(mi)dinil-dihidrospiro- /cikloalkilamin/-pirimido/1,2-a/pirimidin-6-ona | |
RS50606B (sr) | Supstituisani morfolin i tiomorfolin derivati | |
HRP20040429B1 (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
RS53379B (en) | N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND THE PROCEDURE FOR THEIR PREPARATION | |
CO5310534A1 (es) | Nuevos derivados de androstano anti-inflamatorios | |
MEP10709A (en) | 2-ARYL-6-PHENYLIMIDAZO[1,2-alpha]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | |
RS52119B (en) | 4-phenylamino-HINAZOLIN-6-IL-STARCHES | |
HRP20080477T3 (en) | Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors | |
HRP20090151T3 (en) | Indozolone derivatives as 11b-hsd1 inhibitors | |
CO5031241A1 (es) | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos | |
ATE253545T1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
RS53348B (en) | PROCEDURE FOR THE PREPARATION OF 3-SUBSTITUTED 2-AMINO-5-HALOBENZAMIDES | |
RS52562B (en) | (3-ARIL-PIPERAZINE-1-IL) DERIVATI 6,7-DIALCOKSIQUINZOLINE, 6,7-DIALCOKSIFTALAZINE I | |
RS53080B (en) | AMINOPHOSPHORIC ACID ETHAR DERIVATIVE AND S1P RECEPTOR MODULATOR CONTAINING THE SAME AS THE ACTIVE INGREDIENT | |
HRP20050213A2 (en) | 2,4-substituted indoles and their use as 5-ht6 modulators | |
EP1490371A4 (en) | TRICYCLIC COMPOUNDS BASED ON THIOPENE AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUNDS | |
RS51674B (en) | PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS | |
MEP24208A (en) | Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics | |
RS50628B (sr) | Derivati(poli)aminoacetamida epipodofilotoksina, postupak za njihovo dobijanje i njihove primene u terapeutici kao sredstva protiv kancera | |
ATE409179T1 (de) | Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten |